Aixia Ma
Overview
Explore the profile of Aixia Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Wang H, Yu K, Ma A, Zhu W, Li T, et al.
Int J Biol Macromol
. 2025 Mar;
307(Pt 1):141872.
PMID: 40068750
Nattokinase from traditional food natto has the potential to be a thrombolytic agent. Its terminal sequence has an important effect on the catalytic performance of nattokinase, but the specific mechanism...
2.
Yu K, Chen L, Tang Y, Ma A, Zhu W, Wang H, et al.
Microb Cell Fact
. 2025 Mar;
24(1):51.
PMID: 40033318
Nattokinase, the thrombolytically active substance in the health food natto, nevertheless, its lower thermostability restricts its use in food and pharmaceutical applications. In this study, two heat-resistant variants of nattokinase,...
3.
Yan X, Wang Y, Ma A, Li H
J Comp Eff Res
. 2025 Feb;
:e240226.
PMID: 39969114
Colorectal cancer (CRC) is among the most prevalent malignancies globally and causes massive resource consumption and economic burden. Health economic evidence (HEE) has been used in clinical practice guidelines (CPGs)...
4.
Ma A, Wang H, Jia H, Yu S, Zhu W, Yu K, et al.
J Agric Food Chem
. 2025 Feb;
73(7):4152-4163.
PMID: 39904540
The nattokinase propeptide acts as an intramolecular chaperone that is essential for the correct folding of the mature peptide. Understanding key catalytic regions and sites in this propeptide is crucial...
5.
Liang Y, Ma A
Medicine (Baltimore)
. 2024 Nov;
103(48):e40678.
PMID: 39612459
Background: To systematically assess the cost-effectiveness of immune checkpoint inhibitors compared to the current standard therapy for human papillomavirus (HPV) and human immunodeficiency virus (HIV)-related cervical cancer. Methods: A partitioned...
6.
Li Y, Zhu W, Chen L, Tang X, Ma A, Ma Y, et al.
Front Nutr
. 2024 Nov;
11:1505584.
PMID: 39610882
Introduction: The poor thermostability of nattokinase represents a significant limitation in its potential applications. Additionally, there is a notable absence of studies focused on modifying residues within the active site...
7.
Li Y, Chen Y, Sun J, Jiang M, Ma A, Tao T, et al.
Eur J Health Econ
. 2024 Sep;
PMID: 39340752
Objective: This study utilized the EQ-5D-Y and the Child Health Utility 9D (CHU-9D) instruments to empirically investigate a general child population aged 7-8 years in China, with the aim of...
8.
Hu H, Zhou T, Gao J, Ou Y, Ma A, Wang P
Front Public Health
. 2024 Sep;
12:1364854.
PMID: 39286743
Background: Bronchiolitis and pneumonia are both significant lower respiratory tract infections with a profound impact on children's health. The purpose of this study is to explore the economic burden and...
9.
Wang Y, Huang Y, Ma A, You J, Miao J, Li J
J Agric Food Chem
. 2024 Aug;
72(34):19258.
PMID: 39162298
No abstract available.
10.
Ma Y, Zhou X, Liu Y, Xu S, Ma A, Du Y, et al.
Helicobacter
. 2024 Aug;
29(4):e13123.
PMID: 39108224
Objective: There is an economic evaluation on the family-based Helicobacter pylori screen-and-treat strategy (FBHS) in China. This study aimed to compare the cost-effectiveness of the FBHS with the traditional H....